The company has said it may need to to raise more cash, but you...

The company has said it may need to to raise more cash, but you know what happens when they do that don't you.

Yep it takes off.

With their product range shaping up very well and FDA approval looking like a very sure thing for Oraline IV, they could do a rights issue to reward all shareholders and then she will be off big time as they market globally.

Oraline IV is Low cost, highly effective, high volume (global + needs to be replaced after use for on going drug screening), meaning there is no end to its revenue potential. A brilliant business to be involved in, as drugs abuse is here to stay unfortunately.